Brief: Palatin Announces U.S. Patent Term Extension For Vyleesi® (Bremelanotide Injection)
04/05/2021 12:32
May 4 (Reuters) - Palatin Technologies Inc PTN.A :
* PALATIN ANNOUNCES U.S. PATENT TERM EXTENSION FOR VYLEESI®
(BREMELANOTIDE INJECTION)
Source text for Eikon: ID:nPnGdK8Pa
Further company coverage: PTN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palatin Technologies
See all newsPalatin Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Palatin Technologies Inc expected to post a loss of $1.20 a share - Earnings Preview
Palatin Technologies Q2 revenue rises yr/yr, net loss widens
Brief: Palatin Announces 1-For-50 Reverse Stock Split
Brief: Palatin Announces Positive Preclinical Efficacy Data For Oral MC4R Agonist PL7737 In Animal Model Of Obesity